Epac activation increased MYPT phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

Cell viability of canine cells treated with the autophagy inhibitor spautin-1, doxorubicin, or a combination, with spautin-1 applied pre-chemotherapy. by Courtney R. Schott (5904980)

Microscopic examination of confrontation zones between <i>C</i>. <i>rosea</i> 100C/1 strain and GTD pathogens. by Adrienn Geiger (13730524)

Solubilized P, dry biomass, pH and titratable acidity in NBRIP medium with Araxá RP (3 g L⁻¹) as the only P source, Ca₃(PO₄)₂ (5 g L<sup... by Ubiana de Cássia Silva (643658)

“…</p>b<p>Mutant with a significant decrease in P solubilization potential (negative mutant).…”

Features and Consequences of Isopropanol Burning off PTFE–rGO Aerogels by Sergey A. Baskakov (11324315)

“…An improved procedure for the preparation of aerogel granules of polytetrafluoroethylene–graphene oxide (PTFE–GO) with a composition of 50:50 (in wt %) and a specific density of 35 ± 2 mg/cm³ is described. …”

Molecular and cellular defects in <i>Sr/+;Nr/+</i> SCO development at 12.5 dpc and 14.5 dpc. by Kristie Lee (186289)

“…<b>D–F:</b> Section <i>in situ</i> hybridisation analysis of <i>Fibcd1</i> expression in 12.5 dpc (D), 15.5 dpc (E) and 18.5 dpc (F) SCO. <b>G,H:</b> Sagittal section <i>in situ</i> hybridisation analysis showing decreased <i>Fibcd1</i> expression in the <i>Sr/+;Nr/+</i> (H) SCO compared with wild type SCO (G) at 12.5 dpc. …”

These heatmaps indicate the number of mutations that accumulate after 5 passages in 5 insects, based on the predictions from the simulation model. by Dieke Boezen (12800457)

“…The purple cross indicates the point in the parameter space that corresponds to the model parameters assumed in model fitting (<i>λ</i> = 46, <i>κ</i> = 5.05 × 10⁸). …”

Baseline characteristics. by David Röthlisberger (17684467)

“…The odds for a fall decreased by a factor of 0.86 (95% CI 0.80 to 0.93) for each increase in blood pressure by 10 mmHg. …”

Comparison of the observed versus simulated mean <i>WAS</i> with models incorporating additional variants. by Yingleong Chan (189964)

“…This model results in a shift in the simulated <i>WAS</i> of the short individuals to the right such that the observed <i>WAS</i> is no longer different from the simulation (<i>p</i> = 0.544). The 5^th row shows a model where there are 10 additional low frequency variants that moderately decreases height (allele frequency = 0.005 and effect size (β) = −1). …”

Skin defects in <i>Hdh</i>^neoQ50/<i>Hdh</i>^ex4/5 hypomorphic embryos. by Vidya Murthy (6495386)

“…<b>A)</b> At E18.5, following toluidine-blue dye exclusion assay, WT animal shows a functional epidermal barrier but <i>Hdh</i>^neoQ50/<i>Hdh</i>^ex4/5 animal has a compromised epidermal barrier on the ventral surface. …”

Kinetics and dose response of distinct changes to HDMEC barriers induced by TNF and IL-β. by Paul R. Clark (714064)

“…A plot of the percent increase over basal TEER values (measured at the peak of the TNF-induced TEER increase, mean 0.7±0.01 hours; y-axis) vs. basal TEER (reported in ohms and read on a 96W20idf ECIS array; x-axis). …”

Analysis of COR week 5 improvers and nonimprovers. by Cornelius Schüle (253896)

“…<p>Mean value graphs of the decrease in 21-HAMD sum scores in 40 depressed patients treated with either reboxetine (n = 20) or mirtazapine (n = 20) for 5 weeks, subdivided into COR week 5 improvers and nonimprovers. …”

Sensitivity of <i>B</i>. <i>subtilis</i> Rho⁺ to fatty acid starvation and heat stress. by Vladimir Bidnenko (4258573)

Data_Sheet_2_Immunotolerant p50/NFκB Signaling and Attenuated Hepatic IFNβ Expression Increases Neonatal Sensitivity to Endotoxemia.docx by Sarah McKenna (5040047)

“…<p>Sepsis is a major cause of neonatal morbidity and mortality. …”

Data_Sheet_1_Immunotolerant p50/NFκB Signaling and Attenuated Hepatic IFNβ Expression Increases Neonatal Sensitivity to Endotoxemia.PDF by Sarah McKenna (5040047)

“…<p>Sepsis is a major cause of neonatal morbidity and mortality. …”

Group mean changes in gait cycle duration during knee perturbation trial and aftereffect. by Kailey Nishimura (6167213)

No effects of fingolimod on spinal cord glutamate transporter protein levels during EAE. by De-Hyung Lee (356687)

“…At the maximum of EAE, there was a decrease for SLC1A2 (A,B) and SLC1A3 protein levels (C,D) as compared to naïve mice which was restored after fingolimod treatment (3 mg/kg once daily). …”

Dataset for: Computationally efficient inference for center effects based on restricted mean survival time by Xin Wang (5458019)

“…Restricted mean survival time (RMST) has gained increased attention in biostatistical and clinical studies. …”

Epac activation increased RLC phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

A comparison of METH or AMP brain and serum concentrations over time, after a 0.56 mg/kg <i>ip</i> injection of METH, between AAV-scFv6H4, AAV-scFv7F9, and a saline control at day... by Charles E. Hay (5470526)